Search for Clinical Trial Results

Sponsored By

Myelodysplastic/myeloproliferative Disease - 7 Studies Found

Status Study
Recruiting Study Name: A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, and Myelofibrosis
Condition:
  • Leukemia, Myelocytic, Acute
  • Myelodysplastic Syndrome (MDS)
  • Date: 2014-06-05
    Interventions: Drug: CPI-0610
Completed Study Name: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • M
    Date: 2004-10-06
    Interventions:
    • Biological: etanercept
    • Drug: arsenic triox
Completed Study Name: Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • M
    Date: 1999-11-01
    Interventions: Biological: sargramostim
Completed Study Name: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • M
    Date: 2003-01-24
    Interventions: Dietary Supplement: doxercalciferol
Completed Study Name: Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • M
    Date: 2003-01-27
    Interventions:
    • Drug: carboplatin Carboplatin

Completed Study Name: Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • M
    Date: 2000-09-11
    Interventions:
    • Drug: sodium phenylbutyrate
    • Drug: tretinoi
Completed Study Name: Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition:
  • Leukemia
  • Myelodysplastic Syndromes
  • M
    Date: 2000-03-07
    Interventions:
    • Drug: azacitidine
    • Drug: sodium phenylbutyr